DRW Securities LLC Buys Shares of 26,800 Sharecare, Inc. (NASDAQ:SHCR)

DRW Securities LLC bought a new stake in shares of Sharecare, Inc. (NASDAQ:SHCR) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 26,800 shares of the company’s stock, valued at approximately $38,000.

Several other institutional investors also recently bought and sold shares of the company. Gabelli Funds LLC acquired a new stake in shares of Sharecare during the second quarter worth about $892,000. XTX Topco Ltd purchased a new stake in Sharecare during the 2nd quarter worth approximately $42,000. Hsbc Holdings PLC lifted its holdings in Sharecare by 46.4% during the 2nd quarter. Hsbc Holdings PLC now owns 215,216 shares of the company’s stock worth $296,000 after buying an additional 68,246 shares in the last quarter. Vanguard Personalized Indexing Management LLC purchased a new position in Sharecare in the 2nd quarter valued at approximately $42,000. Finally, Renaissance Technologies LLC grew its stake in shares of Sharecare by 26.4% in the second quarter. Renaissance Technologies LLC now owns 831,600 shares of the company’s stock worth $1,123,000 after acquiring an additional 173,800 shares in the last quarter. 35.08% of the stock is owned by institutional investors and hedge funds.

Sharecare Stock Performance

Shares of SHCR stock opened at $1.41 on Wednesday. The company has a market cap of $511.00 million, a P/E ratio of -3.81 and a beta of 0.50. The firm has a fifty day moving average price of $1.39 and a 200 day moving average price of $1.08. Sharecare, Inc. has a 12 month low of $0.48 and a 12 month high of $1.42.

Sharecare (NASDAQ:SHCR) last announced its quarterly earnings results on Friday, August 9th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.03). Sharecare had a negative return on equity of 22.81% and a negative net margin of 33.64%. The business had revenue of $94.27 million for the quarter, compared to analysts’ expectations of $90.16 million. On average, equities analysts forecast that Sharecare, Inc. will post -0.24 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on SHCR. Canaccord Genuity Group cut Sharecare from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 21st. Morgan Stanley lifted their price objective on Sharecare from $1.00 to $1.43 and gave the company an “equal weight” rating in a research note on Monday, June 24th. Finally, Canaccord Genuity Group restated a “hold” rating and set a $1.43 target price (down from $2.00) on shares of Sharecare in a research note on Friday, June 21st.

Insider Activity at Sharecare

In other Sharecare news, insider Jeffrey T. Arnold sold 177,085 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $1.38, for a total transaction of $244,377.30. Following the sale, the insider now owns 4,790,406 shares of the company’s stock, valued at $6,610,760.28. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 29.27% of the stock is currently owned by corporate insiders.

Sharecare Company Profile

Sharecare, Inc operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being.